Salvage therapy in patients with glioblastoma: is there any benefit?

Hau, Peter, Baumgart, Ulrike, Pfeifer, Katharina, Bock, Anne, Jauch, Tanya, Dietrich, Jörg, Fabel, Klaus, Grauer, Oliver, Wismeth, Caecilia, Klinkhammer-Schalke, Monika, Allgäuer, Michael, Schuierer, Gerhard, Koch, Horst, Schlaier, Juergen, Ulrich, Winfried, Brawanski, Alexander, Bogdahn, Ulrich und Steinbrecher, Andreas (2003) Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98 (12), S. 2678-2686.

Im Publikationsserver gibt es leider keinen Volltext zu diesem Eintrag.

Zum PubMed-Eintrag dieses Artikels

Zum Artikel beim Verlag (über DOI)

Zusammenfassung

The majority of patients in the current series were treated with a reintervention strategy, which had an impact on PFS and mOS. A second resection, focal radiotherapy (in selected cases), and additional chemotherapeutic regimens should be considered for patients with recurrent glioblastoma.

Bibliographische Daten exportieren

Dokumentenart:

Artikel

Datum:

2003

Institutionen:

Medizin > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)

Identifikationsnummer:

Wert	Typ
14669289	PubMed-ID
10.1002/cncr.11845	DOI

Klassifikation:

Notation	Art
Adult	MESH
Aged	MESH
Aged, 80 and over	MESH
Antineoplastic Agents/therapeutic use	MESH
Brain Neoplasms/mortality	MESH
Cohort Studies	MESH
Combined Modality Therapy	MESH
Female	MESH
Follow-Up Studies	MESH
Glioblastoma/mortality	MESH
Humans	MESH
Karnofsky Performance Status	MESH
Male	MESH
Middle Aged	MESH
Neoplasm Recurrence, Local/drug therapy	MESH
Neoplasm Staging	MESH
Quality of Life	MESH
Radiotherapy Dosage	MESH
Reoperation	MESH
Retrospective Studies	MESH
Salvage Therapy	MESH
Survival Rate	MESH